Cancers, Vol. 12, Pages 3329: Current Advances and Hurdles in Chimeric Antigen Receptor Technology

Alexandros G.Sfakianakis shared this article with you from Inoreader Cancers, Vol. 12, Pages 3329: Current Advances and Hurdles in Chimeric Antigen Receptor Technology Μέσω Cancers Cancers, Vol. 12, Pages 3329: Current Advances and Hurdles in Chimeric Antigen Receptor Technology Cancers doi: 10.3390/cancers12113329 Authors: Scott McComb Seung-Hwan Lee Since tumor-specific T cells were first utilized to treat melanoma patients in 1986 [...] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.